You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 11, November 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Possible Mechanism of Piroxicam-Induced Photosensitivity

Irene E. Kochevar, PhD; Warwick L. Morison, MD; Joel L. Lamm, MD; Daniel J. McAuliffe; Andre Western, PhD; A. F. Hood, MD

Arch Dermatol. 1986;122(11):1283-1287.


Abstract

{dagger} The therapeutic use of piroxicam as a nonsteroidal anti-inflammatory agent is associated with the development of photosensitivity in less than 1% of patients. The eruption usually occurs within a few days of commencing treatment with the medication. This time course suggests a phototoxic reaction. Attempts to demonstrate the phototoxic effects of piroxicam in humans, laboratory animals, and in in vitro cell assays were unsuccessful. At high concentration, however, one metabolite of piroxicam was phototoxic in animal studies and in in vitro assays. A second metabolite was mildly phototoxic in laboratory animals. These results suggest a mechanism whereby piroxicam photosensitivity may be due to a metabolite preferentially formed or accumulated in affected patients.

(Arch Dermatol 1986;122:1283-1287)



Author Affiliations

From the Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Kochevar and Western and Mr McAuliffe); the Department of Dermatology, The Johns Hopkins University, Baltimore (Drs Morison, Lamm, and Hood), and the National Cancer Institute-Frederick Cancer Research Facility, Frederick, Md (Dr Morison).


Footnotes

Accepted for publication June 4, 1986.

The contents of this publication do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.

Reprint requests to Wellman Laboratories, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114 (Dr Kochevar).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Uses of Nonsteroidal Anti-inflammatory Drugs in Pediatrics
Lindsley
Arch Pediatr Adolesc Med 1993;147:229-236.
ABSTRACT  

Photosensitizing Potential of Certain Nonsteroidal Anti-inflammatory Agents
Kaidbey and Mitchell
Arch Dermatol 1989;125:783-786.
ABSTRACT  

Phototoxicity of Nonsteroidal Inflammatory Drugs: Coincidence or Specific Mechanism?
Kochevar
Arch Dermatol 1989;125:824-826.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.